PolyMED is a private equity fund based in Lyon, France. According to its most recent Form D, filed Aug 14, 2020, it has sold $28,202,713 of interests to 5 investors since its first sale in Jul 2020. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include ArchiMed SAS.
- Total raised
- $28,202,713Cumulative sales reported on Form D
- Investors
- 5
- First sale
- Jul 31, 2020
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- ArchiMed SAS
- Latest Form D
- Aug 14, 2020
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about PolyMED
What is the minimum investment for PolyMED?
PolyMED's latest Form D, filed Aug 14, 2020, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in PolyMED?
PolyMED is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has PolyMED raised?
PolyMED reports $28,202,713 sold from 5 investors on its Form D filed Aug 14, 2020. This is cumulative sales since the offering began, not current assets or performance.
Where is PolyMED based?
PolyMED is based in Lyon, France.
When did PolyMED launch?
PolyMED reports its first sale in Jul 2020.
Size compared with every private equity fund
Raised more than 59% of the 22 private equity funds based in France, and more than 56% of all 8,842 that report sales.